Status:
COMPLETED
Research on the Accurate Diagnosis of Urinary Tract Tumors and the Development of Kits
Lead Sponsor:
Zhongnan Hospital
Conditions:
Bladder Cancer
Urothelial Carcinoma
Eligibility:
All Genders
18+ years
Brief Summary
Bladder cancer is the second most prevalent urological malignancy worldwide, with a high incidence and poor patient prognosis. Achieving early diagnosis and intervention for bladder cancer is one of t...
Detailed Description
In response to the clinical demand for accurate early diagnosis of bladder cancer, this project aims to gradually conduct in-depth research on precise early diagnosis of bladder cancer. This includes ...
Eligibility Criteria
Inclusion
- Age ≥ 18 years with defined gender;
- Preoperative patients are preliminarily evaluated as bladder tumors by cystoscopy, FISH, cytology, or imaging.
Exclusion
- Aged \<18 years;
- Post-operative or after anti-tumor treatment such as chemotherapy or immunotherapy
- History of other malignant tumors
- Specimens with hemolytic conditions;
- Patients with incomplete, undocumented, and uncooperative data.
Key Trial Info
Start Date :
June 1 2023
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
December 1 2023
Estimated Enrollment :
400 Patients enrolled
Trial Details
Trial ID
NCT06193941
Start Date
June 1 2023
End Date
December 1 2023
Last Update
January 9 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Zhongnan Hospital of Wuhan University
Wuhan, Hubei, China, 430071